Sibo Jiang

Company: SanegeneBio

Job title: VP of CMC

Seminars:

Navigating Oligonucleotide Early CMC Development Challenges With Late-Stage Readiness in Mind 10:00 am

• As a new therapeutic modality with emerging novel approaches, oligonucleotide CMC development comes with its own challenges • Understanding that a good early-stage CMC development strategy is essential for future late-stage and commercial success • Establishing phase-appropriate and forward-looking CMC development strategies for novel oligonucleotide therapeuticsRead more

day: Day Two